Moviprep

Ascorbic Acid, the active ingredient in Moviprep, is an osmotic laxative presented as an oral solution for oral use. It creates an osmotic gradient that draws water into the intestinal lumen, inducing rapid evacuation, and is employed to cleanse the bowel before endoscopic examinations such as colonoscopy and sigmoidoscopy, facilitating clear visualization of the intestinal mucosa.

GNH USA supplies Moviprep as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and providing reliable global distribution.

Moviprep is an osmotic bowel preparation used to cleanse the colon before diagnostic procedures.

Colonoscopy: provides rapid bowel evacuation to allow clear visualization of the colon. Sigmoidoscopy: cleanses the distal colon for accurate examination. Pre‑operative bowel preparation: reduces fecal load before certain surgeries.

Common Side Effects: - Nausea - Abdominal cramping - Bloating - Vomiting Serious or Rare Side Effects: - Severe dehydration - Electrolyte imbalance (e.g., hyponatremia, hypokalemia) - Acute renal impairment

Before prescribing Moviprep, consider the following precautions: - Assess renal function: evaluate kidney status before initiating therapy. - Monitor electrolytes: check serum sodium and potassium during preparation. - Avoid in severe dehydration: ensure patient is adequately hydrated. - Use with caution in cardiac disease: consider risk of electrolyte shifts. - Store at ambient temperature: keep in original container, protect from moisture.

Moviprep may interact with other medications as follows: Major Interactions (Avoid): - Loop diuretics: increase risk of electrolyte depletion. - Other osmotic laxatives: additive osmotic load may cause severe dehydration. - Lithium: altered renal clearance may raise lithium levels. Moderate Interactions (Monitor Closely): - NSAIDs: may impair renal function when combined. - ACE inhibitors: potential for renal impairment with volume loss. - Opioids: may reduce bowel motility and diminish efficacy.